Fig. 1From: Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapymRNA expression analysis of DNA damage response (DDR) regulator genes, and MGMT promoter methylation analysis in human GBM cell lines. A Basal mRNA expression levels of DDR regulator genes in GBM cell lines A172, LN18, LN229, T98G, U87-MG, U138-MG, and U251-MG as measured by qRT-PCR (ddCT method). Expression levels were normalized to a matrix of three reference genes (18S rRNA, β2-Microglobulin, and 5’-Aminolevulinate Synthase-1), and calibrated on the expression levels of astrocytes. Three replicates were analyzed per cell line. Expression values (log2-transformed) and samples were subjected to unsupervised hierarchical clustering. B Correlation of MGMT promoter methylation status and MGMT mRNA expression levels in the employed GBM cell lines as detected by methylome array and qRT-PCR, respectively. C Protein expression levels of MGMT in GBM cells as measured by western blot. Vinculin served as loading controlBack to article page